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Background
The purpose of this study is to understand the mechanism
of traumatic optic neuropathy (TON) in order to prevent
vision loss. Following traumatic insults to the optic nerve,
retinal microglia cells are activated through MAP Kinase
pathways and increased cytotoxic activity that causes ret-
inal ganglion cell death [1]. Under stress condition, extra-
cellular concentration of adenosine is likely to increase
and activates an anti-inflammatory pathway through A2A
adenosine receptor. But in TON, the accumulated extra-
cellular adenosine is then transported intracellular through
equilibrative nucleoside transporters (ENTs) which further
gets converted into AMP by Adenosine kinase (AK),
which results in low extracellular adenosine concentration.
We have demonstrated that microglia activation and
TNF-a release was inhibited by AK inhibitor. Based on
these findings, we hypothesize that an imbalance in adeno-
sine formation and metabolism in the retinal microglia
participated by AK may contribute significantly to retinal
complications in the setting of TON.
Materials and methods
Mice were anesthetized according to standard protocol
and bilateral limbal conjunctival peritomy was performed
posteriorly to the optic nerve in each mouse. Mice were
treated with or without an AK inhibitor (AKI), ABT702
(25μg/kg; i. p.), every other day for 7 days. All retinas or
eye ball were then harvested for protein, histology and
RNA expression.
Results
We found that in TON, RGC number significantly
decreased, Cleaved Caspase-3, Iba1, cd11b expression
and TUNEL positive cells increased as compared with
control eye (Fig 1 A-C). In a series of experiments with
Western Blot, Immunohistology and Real-Time PCR,
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Figure 1 A) H & E staining of TON eye section for RGC counting. B) Quantitative analysis of TUNEL-positive cells in the retinal cross section of
TON and control. Immunohistochemical analysis of activated Caspase-3 in retinal section of TON vs. control. C) Immunohistochemical and
Immunoblotting of microglial activation marker Iba-1 and CD11b expression in TON vs. control.
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increased expression of TNF-a, Iba1, iNOS and IL-6
were shown in nerve crush model as compared with
AKI treatment. It was also noted that administration of
AKI showed no effect in the control.
Conclusions
Based on our findings, we conclude that Adenosine Kinase
inhibition may have potential role in regulating inflamma-
tory mechanism in TON mouse model.
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